Archives
-
Podophyllotoxin Derivative 5p and MDR
2026-09-02
The reference study shows that podophyllotoxin derivative 5p combines catalytic topoisomerase IIα inhibition with suppression of microtubule polymerization, producing activity against several multidrug-resistant cancer models. Its effects connect target inhibition with G2/M arrest, apoptosis, pyroptosis, reduced drug-efflux protein expression, and impaired resistant-tumor growth in xenografts.
-
Aztreonam for Reliable Cell and Microbial Assays
2026-09-02
Aztreonam (SKU A5931) supports mechanism-aware Gram-negative research while highlighting critical controls for cell viability, progenitor-cell, and hepatic enzyme studies. This scenario-driven guide covers interpretation, solution preparation, assay compatibility, and practical supplier selection.
-
Leucovorin Calcium in Antifolate Assays
2026-09-01
Leucovorin Calcium enables controlled methotrexate-rescue experiments in cell lines, organoids, and tumor–stroma assembloids. This workflow uses calcium folinate to separate folate-pathway protection from microenvironment-driven drug resistance, improving the interpretability of viability and proliferation data.
-
Triamcinolone B1859: In Vitro Workflow Guide
2026-09-01
Triamcinolone B1859 provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid signaling, inflammation, and immunosuppression. This guide explains preparation, assay controls, QC, and handling boundaries for research use; it is not intended for diagnostic, therapeutic, or clinical applications.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-08-31
The reference study developed chemically modified p21 mRNA packaged in lipid nanoparticles for localized intravesical treatment of bladder cancer. Its preclinical data connect restored nuclear p21 expression with cell-cycle inhibition, DNA-damage signaling, apoptosis, and reduced tumor growth, while also highlighting delivery and manufacturing questions for future translation.
-
WAY-100635: A Causal Probe for Pain Circuits
2026-08-31
WAY-100635 enables precise serotonin receptor antagonist research by testing whether 5-HT1A signaling contributes to sensory, affective, and cognitive pain phenotypes. This article presents an assay-centered framework that extends cannabidiol findings without overstating serotonergic mechanism.
-
Açaí Extracts in Human Hepatocytes: Key Findings
2026-08-30
Raichura and colleagues evaluated consumer-relevant açaí extracts for hepatocyte cytotoxicity and modulation of drug-metabolizing enzymes and transporters. The study found extract-specific, dose- and time-dependent loss of viability but no significant induction of the tested CYP450 or transporter genes, highlighting why botanical-drug interaction studies must distinguish cellular toxicity from pathway activation.
-
MOG (35-55) Peptide: A Mechanistic EAE Guide
2026-08-29
Explore how the MOG (35-55) myelin oligodendrocyte glycoprotein peptide supports reproducible EAE and multiple sclerosis research. This guide connects antigen-driven disease modeling with the PARP7–STAT1/STAT2 pathway and translates that insight into practical assay decisions.
-
Neurospora EGO-like Complex Regulates TOR Signaling
2026-08-28
The reference study defines how the VTA–GTR2 EGO-like system controls nutrient-responsive TORC1 activity and localization in Neurospora crassa. Its findings distinguish amino acid sensing from glucose-dependent regulation and connect vacuolar positioning of TORC1 with a possible mechanism linking metabolism to circadian rhythmicity.
-
ATP Solution (100 mM): Reliable Assay Workflows
2026-08-28
Learn how ATP Solution (100 mM), SKU K1043, supports controlled kinase, transcription, ligation, and phosphorylation workflows that influence cell-proliferation and cytotoxicity research. This scenario-based guide covers compatibility, optimization, interpretation, storage, and practical vendor selection.
-
Luminescent ATP Detection Assay Kit for CRC ICD
2026-08-27
Translate extracellular ATP release and intracellular energy loss into quantitative evidence for immunogenic cell death studies. The Luminescent ATP Detection Assay Kit combines gentle lysis, broad-range firefly luciferase detection, and compatibility with downstream protein workflows for more informative cancer experiments.
-
CTP Solution for mRNA-LNP Workflows
2026-08-27
CTP Solution (100 mM) provides a defined, nuclease-free cytidine triphosphate input for IVT, RNA amplification, and translational mRNA-LNP research. This guide connects precise nucleotide handling with the localized p21 mRNA-LNP strategy reported for bladder cancer while separating product specifications from workflow recommendations.
-
Influenza Hemagglutinin (HA) Peptide Workflow
2026-08-26
Use the Influenza Hemagglutinin (HA) Peptide as a reversible elution reagent for HA-tagged proteins, interaction complexes, and carefully designed exosome assays. This guide connects competitive antibody binding with practical immunoprecipitation workflows and the RAB31-centered exosome pathway described in the reference study.
-
Alosetron in Intestinal Signaling Research
2026-08-26
Alosetron offers a selective way to perturb 5-HT3 receptor signaling while researchers measure epithelial polarity, stem-cell fate, and gastrointestinal function. This guide converts the CDC42–YAP/TAZ–Ereg–mTOR findings into practical assay designs, controls, and troubleshooting workflows.
-
Calpain Inhibitor I, ALLN: Protocol Guide
2026-08-25
Calpain Inhibitor I (ALLN, SKU A2602) is a DMSO-prepared cysteine-protease inhibitor for workflows requiring modulation of calpain I/II and cathepsin B/L, including apoptosis assays and ischemia-reperfusion injury models. It is insoluble in water, has no universal cellular or in vivo dose in the supplied dossier, and should not be used for clinical, diagnostic, or water-only protocols.